Novo Nordisk A/S (NYSE:NVO)

50.96
Delayed Data
As of Jun 14
 -0.74 / -1.43%
Today’s Change
41.23
Today|||52-Week Range
52.83
+10.61%
Year-to-Date

Today’s Trading

Previous close51.70
Today’s open51.26
Day’s range50.90 - 51.59
Volume1,230,516
Average volume (3 months)1,340,285
Market cap$89.2B
Data as of 4:02pm ET, 06/14/2019

Growth & Valuation

Earnings growth (last year)+8.07%
Earnings growth (this year)+0.13%
Earnings growth (next 5 years)+8.90%
Revenue growth (last year)+4.51%
P/E ratio21.4
Price/Sales6.31
Price/Book14.88

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.01-0.02%
AZNAstraZeneca-0.24-0.60%
SNYSanofi-0.21-0.49%
BMYBristol-Myers Squibb+0.23+0.49%
Data as of 4:02pm ET, 06/14/2019

Financials

Next reporting dateAugust 9, 2019
EPS forecast (this quarter)$0.61
Annual revenue (last year)$17.7B
Annual profit (last year)$6.1B
Net profit margin34.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts